Abstract
We would like to share ideas on “Neuronal Ceroid Lipofuscinosis: Clinical and Laboratory Profile in Children from Tertiary Care Centre in South India.”[1] Prajapati et al noted that “Infantile onset with thalamic atrophy on MRI is common in CLN1 and refractory epilepsy, visual impairment, and specific EEG changes are common … diagnosis and genetic testing in subtyping. Thus, a multimode approach played a role in the diagnosis of NCL.”[1] We agree that observations in the present report might be clinically useful. Some clinical features might be more common in CLN1, whereas others are more common in CLN2. The observed patterns in a previous Indian report showed some differences.[2] Due to the few patients and since there is no statistical proof for difference, the observed clinical features might not be able to discriminate and might not “helpful in selecting enzyme assay for CLN1 versus CLN2.”
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
